Novartis Home

Male scientist in lab working with his colleagues

At Novartis, we are reimagining medicine

Novartis signs initial agreement to provide manufacturing capacity for CureVac COVID-19 vaccine candidate

The agreement will see Novartis utilizing its new high-tech production facilities in Kundl, Austria.

Read More

Annual General Meeting 2021

The Novartis Annual General Meeting took place on March 2, 2021 in Basel, Switzerland.

Watch the recording

Annual Reporting 2020

Explore digital versions of the Annual Review 2020, Novartis in Society ESG Report 2020 and previous reports in the Annual Reporting microsite.

Learn More

25 Years of Novartis

From dyes and chemicals to breakthrough innovation. Although only 25 years young, Novartis has a rich company history that roots back more than 250 years.

Watch video

Novartis COVID-19 Information Center

Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.


From Cancer to Cures

Our new monthly series "Let's Talk About the C Word: From Cancer to Cures" featuring President of Novartis Oncology Dr. Susanne Schaffert, addresses challenging cancer related topics.

Learn More

Our commitment to ethical and responsible use of AI

AI is helping Novartis improve patients’ lives and optimize the healthcare ecosystem. We are committed to deploying AI systems in a transparent and responsible way.

Learn More

Clinical Trials at Novartis

Discover how patients and healthy volunteers get involved in clinical trials to help bring innovative medicines to people.

Learn More

Digital innovation in the 2021 healthcare agenda

Two Novartis leaders share their perspectives on digital health in 2020 – and the key trends to watch out for over the next 12 months.

Learn More